theheart.org : Arrhythmia/EP

Arrhythmia/EP

Cardiac Resynchronization Therapy: Do Recent Data Warrant a Change in the Guidelines?

Jan 28, 2010 16:24 EST

Join Drs. Prystowsky and Wilber as they discuss the results of pivotal cardiac resynchronization therapy trials in heart failure and their potential impact on the current treatment paradigm and guidelines.

Arrhythmia/EP

Risk Stratification in HF and CRT: How Do We Reconcile LV Ejection Fraction, QRS Duration, and NYHA Class?

Jan 27, 2010 10:59 EST

Join Drs. Marchlinski, Bax, and Estes for a discussion on recent CRT-D trials, the impact of therapy in early-stage HF patients, and how LVEF, QRS duration, and NYHA class may guide treatment.

Arrhythmia/EP

Contemporary Management of Arrhythmia: Practice-Based Approaches

Jan 20, 2010 13:58 EST

Advances have improved the ability to diagnose, prevent, and treat cardiac arrhythmias and associated conditions. Learn about ongoing improvements in arrhythmia management from a stellar Mayo Clinic faculty.

Arrhythmia/EP

Advances in Cardiac Resynchronization Therapy and Left Ventricular Reverse Remodeling in Heart Failure

Dec 22, 2009 10:19 EST

Join Drs. Fonarow, Gold, and Klein as they discuss recent clinical trial data in cardiac resynchronization therapy and left ventricular reverse remodeling in early-stage heart failure patients.

Imaging

Trials and Tribulations: Debating Controversial Topics in Cardiovascular Disease

Dec 21, 2009 09:48 EST

Fellows from The Mayo Clinic, Duke University, and The Cleveland Clinic discuss challenging cases with their mentors.

Arrhythmia/EP

Risk Stratification in Hypertrophic Cardiomyopathy: ICD Therapy

1 COMMENT - Dec 17, 2009 13:30 EST

Join Drs. Prystowsky and Estes as they discuss risk stratification of patients with hypertrophic cardiomyopathy and strategies for implementing implantable device therapy.

Arrhythmia/EP

Pharmacologic Advances in Atrial Fibrillation: Achieving Optimal Antiarrhythmic and Cardiovascular Outcomes

2 COMMENTS - Dec 17, 2009 10:15 EST

Join Drs. Camm, Freemantle, and Connolly as they discuss a meta-analysis of antiarrhythmic agents and their impact on cardiovascular outcomes.

Acute Coronary Syndromes

Translating Evidence From Trials With Antiplatelet Agents Into Clinical Practice

Dec 8, 2009 10:03 EST

Recently reported and new trials of antiplatelet therapy continue to redefine optimal management strategies for patients with atherothrombotic disease and patients with atrial fibrillation. Drs. Harrington, Angiolillo, Bhatt, Connolly, Mehta, and Simon discuss guidelines? recommendations for the use of antiplatelet therapies and the potential impact of emerging data regarding currently used and novel antiplatelet agents.

Arrhythmia/EP

Improving the Day-to-Day Management of Patients with Atrial Fibrillation

Dec 7, 2009 15:02 EST

Join Drs. Prystowsky, Camm, and Pepine for a discussion on late-breaking results from the RecordAF registry presented at AHA 2009.

Arrhythmia/EP

Atrial Fibrillation Stroke Prevention: A Latin American Perspective

Nov 25, 2009 17:05 EST

A high-risk patient for stroke, stent thrombosis, and bleeding presents a difficult but not unusual challenge. Drs. Lopes, Granger, and Alexander discuss how to balance the risks.

Arrhythmia/EP

Challenges in Warfarin Use and Future Directions of Stroke Prevention in Patients With Atrial Fibrillation: A Global Perspective

2 COMMENTS - Nov 25, 2009 11:27 EST

When is an effective, inexpensive, generic drug a liability? Such is the case for warfarin when reliable monitoring is either not available or untrustworthy. In many areas of the world, including rural areas of the United States and Latin America, eligible patients go untreated and are at risk for stroke. What does the future hold? Join Drs. Garcia, Carvalho, Granger, and Alexander for a discussion.

Arrhythmia/EP

Breaking Down the Walls in Atrial Fibrillation Therapy

1 COMMENT - Nov 23, 2009 09:23 EST

Atrial fibrillation affects nearly 7 million people in the United States and Europe. Please join Drs. Breithardt, Connolly, Crijns, Kirchhof, and Naccarelli for a discussion on strategies to improve outcomes in patients with AF.

Arrhythmia/EP

Identifying Atrial Fibrillation - Preventing Stroke

Nov 13, 2009 09:32 EST

Join Dr. Naccarelli as he leads a panel of experts consisting of Drs. Oseroff, Capucci and Lau, in a discussion.

Arrhythmia/EP

New Therapeutic Strategies in the Management of Atrial Fibrillation

Oct 27, 2009 11:31 EDT

Atrial fibrillation is associated with a high risk for stroke, myocardial infarction, heart failure, and death. How does blockade of the renin-angiotensin system affect patient outcomes? Join our international panel of experts, Drs Camm, Connolly, Crijns, and Granger, as they discuss the ESC 09 hotline results of the ACTIVE-I trial.

Arrhythmia/EP

Preventing Stroke in Patients With Atrial Fibrillation: Late-Breaking Clinical Trial Data From ESC 2009

Oct 19, 2009 14:03 EDT

Read Dr. Jonathan Piccini's review of prevention of stroke in AF and how the newly released results of clinical trials of novel antithrombotic agents will reduce the risk for stroke. Then listen to our international panel of experts, Drs. Camm, Granger, Prystowsky, and Yusuf, as they give their take on new data released at ESC 2009.

Arrhythmia/EP

Does Early Intervention With CRT-D Improve Outcomes for Patients With Heart Failure?

2 COMMENTS - Oct 9, 2009 13:43 EDT

Dr. Ileana Piña discusses the design and outcomes of the MADIT-CRT trial with Drs. Moss and Estes, and how these new data may benefit patients with heart failure.

Arrhythmia/EP

Making the Case for Guideline-Driven Care in the Outpatient HF Setting

1 COMMENT - Oct 7, 2009 10:41 EDT

Evidence-based therapies, both pharmacologic and devices are well documented in published guidelines, but are they followed and implemented in practice? Is there a treatment gap? Is it all about education or the lack thereof? Drs. Yancy, Abraham, and Pfeffer confer on evidence from recent registries and trials.

Arrhythmia/EP

In Depth Review of Late-Breaking Clinical Trials in AF Stoke Prevention

Oct 5, 2009 11:55 EDT

Join our international panel of experts, Drs. Lip, Halperin, Weitz, Ezekowitz, Wallentin, and Connolly as they present late-breaking results of the RE-LY trial.

Arrhythmia/EP

Redefining the Therapeutic Goals of Atrial Fibrillation

3 COMMENTS - Sep 22, 2009 14:20 EDT

AF is sometimes considered a benign or nuisance condition. However, it is vital that it is recognized as a harbinger of underlying cardiovascular disease, and that it is diagnosed early and treated appropriately. Join Drs. Kirchhof, Dorian, Marrouche, and Steg as they discuss strategies to reduce the complications of AF.

Arrhythmia/EP

First Response -- Improved Outcomes in Heart Failure: A First Look at Late-Breaking Data From ESC 2009

1 COMMENT - Aug 26, 2009 11:54 EDT

Does early intervention with CRT-D slow the progression of heart failure? Watch as Dr. David Cannom interviews Drs. Camm, Hlatky, Klein, Moss and Page, and gets their expert opinions on late-breaking clinical trial data released at ESC 09 and how it will affect patient care.

Arrhythmia/EP

Guidelines for Atrial Fibrillation in Transition- New Trial Data and Patient Care

3 COMMENTS - Jul 29, 2009 15:00 EDT

The ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation were published in 2006. Since this publication, new data and treatment options have been developed. Join Drs. Prystowsky, Hohnloser, and Kowey, as they discuss these new data and strategies for implementation in clinical practice.

Arrhythmia/EP

The Interplay Between AF and Hypertension

Jul 24, 2009 14:15 EDT

Hypertension plays a key role in the pathogenesis of atrial fibrillation. Join our expert panel, Drs. Agabiti-Rosei, Allessie, Crijns, Israel, and Weber for a discussion of the current data and treatment options for optimal management and improving outcomes in hypertensive patients with AF.

Arrhythmia/EP

Magnetic Resonance Imaging in Pacemaker Patients: Hot Topics for the Implanting Physician

Jul 16, 2009 13:00 EDT

Join Prof. Santini and Drs. Gimbel and Sommer as they discuss the outstanding challenges surrounding the safety of MRI in patients with implantable cardiac pacing devices and highlight emerging strategies and technological advances that may help increase access to diagnostic care for patients.

Arrhythmia/EP

MRI Safety in Pacemaker Patients: Obstacles and Advances

1 COMMENT - Jul 16, 2009 11:00 EDT

Do we have enough data to suggest that MRI in pacemaker patients is safe? Join Dr. Roger Luechinger as he discusses safety concerns and novel approaches to overcome some of the existing limitations associated with imaging this population of patients.

Imaging

Imaging and Risk Stratification in Heart Failure: An Expert Interview With Jeroen Bax, MD, PhD

1 COMMENT - Jul 14, 2009 11:30 EDT

Dr. Jeroen Bax, on the cusp of publishing a landmark paper to validate the role of MIBG imaging in risk stratifying patients with heart failure, provides a snapshot of his study in this interview from Europace 2009.